Tue, July 18, 2023

Charles Duncan Reiterated (BIVI) at Buy and Held Target at $110 on, Jul 18th, 2023

Charles Duncan of Cantor Fitzgerald, Reiterated "BioVie Inc." (BIVI) at Buy and Held Target at $110 on, Jul 18th, 2023.

Charles has made no other calls on BIVI in the last 4 months.



There is 1 other peer that has a rating on BIVI. Out of the 1 peers that are also analyzing BIVI, 0 agree with Charles's Rating of Hold.



This is the rating of the analyst that currently disagrees with Charles


  • Jay Olson of "Oppenheimer" Reiterated at Buy and Held Target at $120 on, Wednesday, May 17th, 2023